Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$4.81 - $5.57 $841,749 - $974,750
-175,000 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$5.15 - $6.55 $126,690 - $161,130
-24,600 Reduced 12.32%
175,000 $975,000
Q4 2017

Feb 02, 2018

SELL
$6.74 - $9.23 $171,196 - $234,442
-25,400 Reduced 11.29%
199,600 $1.75 Million
Q3 2017

Oct 25, 2017

BUY
$5.44 - $7.7 $1.22 Million - $1.73 Million
225,000
225,000 $1.46 Million

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $40.6M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track This Portfolio

Track Heartland Advisors Inc Portfolio

Follow Heartland Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Advisors Inc with notifications on news.